A mite-y use of electricity A fascinating example of how some creatures sense and rely on electric fields for survival Date: January 28, 2025 Source: University of Connecticut Summary: Mites who ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

But experts actually say that doing this may create the perfect environment for dust mites. Not familiar with these tiny creatures? They can live in your home and, according to research published ...

Tiny mites seem capable of relying on the power of static cling to hop into hummingbird nostrils and move between flowers. By Douglas Main Flower mites spend their lives slurping nectar and ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Among these are Demodex mites, which quietly live, crawl, and reproduce in the pores of your face. While they might look peculiar under a microscope, these mites are a natural part of your skin’s ...

Mites are capable of producing offspring without the aid of a partner. The children are exact replicas of their singular parent, creating a line of pure females. This isn’t a scene from a science ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Demodex brevis is a microscopic mite that lives in the oil glands of human hair follicles. It’s typically found on the face but can also live on other parts of the body. Demodex brevis is a type ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...